SCHEMBL28630713

SCHEMBL28630713

OC1=CC=CC=NO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28636198 0.97
SCHEMBL13723123 0.68
SCHEMBL4789240 0.67
SCHEMBL19859293 0.66
SCHEMBL18322382 0.64
SCHEMBL8903178 0.63 NPSR1 (0.35)
SCHEMBL28007944 0.57
SCHEMBL15690190 0.56
SCHEMBL15690191 0.56
SCHEMBL29536209 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116171280-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-05-26 CN claimed
CN-118206566-A Hydroxypyridooxazepine as NRF2 activator 葛兰素史密斯克莱知识产权发展有限公司 2024-06-18 CN disclosed
CN-113474349-B Hydroxypyridooxazepine as NRF2 activator 葛兰素史密斯克莱知识产权发展有限公司 2024-03-01 CN disclosed
WO-2023210741-A1 BENZOTRIAZOLE COMPOUND 第一三共株式会社 2023-11-02 WO disclosed
CN-116171280-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-05-26 CN disclosed
CN-113474349-A Hydroxypyridooxazepine heptatrienes as NRF2 activators 葛兰素史密斯克莱知识产权发展有限公司 2021-10-01 CN disclosed